Tandem Diabetes Care TNDM Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tandem Diabetes Care's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tandem Diabetes Care's operating lease right-of-use assets in other assets?
- Tandem Diabetes Care (TNDM) reported operating lease right-of-use assets in other assets of $95.74M in Q1 2026.
- How has Tandem Diabetes Care's operating lease right-of-use assets in other assets changed year-over-year?
- Tandem Diabetes Care's operating lease right-of-use assets in other assets decreased by 5.2% year-over-year, from $101.02M to $95.74M.
- What is the long-term trend for Tandem Diabetes Care's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Tandem Diabetes Care's operating lease right-of-use assets in other assets has grown at a 37.2% compound annual growth rate (CAGR), from $19.77M to $96.17M.